Cargando…
Moderators and Other Predictors of Methylphenidate Response in Children and Adolescents with ADHD
Methylphenidate (MPH) is the treatment of first choice for developmental ADHD. To date, no reliable method to predict how patients will respond to MPH exists and conflicting results are reported on clinical characteristics of responders. The present study aims to give a more precise characterization...
Autores principales: | D’Aiello, Barbara, Di Vara, Silvia, De Rossi, Pietro, Pretelli, Italo, Vicari, Stefano, Menghini, Deny |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8834961/ https://www.ncbi.nlm.nih.gov/pubmed/35162663 http://dx.doi.org/10.3390/ijerph19031640 |
Ejemplares similares
-
Gender-Related Clinical Characteristics in Children and Adolescents with ADHD
por: De Rossi, Pietro, et al.
Publicado: (2022) -
Age-related clinical characteristics of children and adolescents with ADHD
por: De Rossi, Pietro, et al.
Publicado: (2023) -
Methylphenidate is more effective to improve inhibitory control and working memory compared to tDCS in children and adolescents with attention deficit/hyperactivity disorder: a proof-of-concept study
por: D’Aiello, Barbara, et al.
Publicado: (2023) -
Comparing the Effect of Methylphenidate and Anodal tDCS on Inhibitory Control and Working-Memory in Children and Adolescents with Attention Deficit/Hyperactivity Disorder: A Study Protocol for a Randomized, within-Subject Trial
por: D’Aiello, Barbara, et al.
Publicado: (2022) -
Risk Factors for Revolving Door in Children and Adolescents with Psychiatric Disorders
por: D’Aiello, Barbara, et al.
Publicado: (2021)